Alliances
The partnership is aimed at creating antibody products that could act as a “protective shield” against infection by the virus that causes COVID-19, SARS-CoV-2.
To date, 10 plasma companies globally have joined the CoVIg-19 Plasma Alliance, founded to accelerate development of a plasma-derived hyperimmune globulin therapy against COVID-19.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for May 7, 2020.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for May 6, 2020.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for May 5, 2020.
Vaccitech Ltd and the University of Oxford announce an agreement with the UK-based global biopharmaceutical company AstraZeneca for the further development, large-scale manufacture and potential distribution of the COVID-19 vaccine candidate currently being trialled by the University.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for May 4, 2020.
The Bill & Melinda Gates Foundation supports international collaboration to expand global access to life-saving vaccines
Notable will offer a grant to support the MDS Foundation’s education and advocacy efforts, and both companies will work closely to engage physicians, biopharmaceutical companies, health authorities and clinical trial organizations to collaborate on clinical trial designs.
Mallinckrodt and Massachusetts General Hospital teamed up to evaluate the potential benefits of inhaled nitric oxide as a treatment for pulmonary complications in patients infected with COVID-19.
PRESS RELEASES